Clinical Trials Browser

Locally Advanced Rectal Carcinoma × envafolimab × Clear all

NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Not yet recruiting

GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma